1. Introduction
Schwannomas (Schs) or neurilemmomas are generally benign tumors which affect patients between the second and the fifth decade twice as frequently in female patients compared to male patients [
1]. The primary origin of Schs is Schwann cells, which are found in all cranial and peripheral nerves. Only three percent arise in the peritoneum, where they grow enormously prior to its diagnosis and subsequently cause clinical difficulties as a consequence of their size; also, Schs represent only up to 5% of all retroperitoneal tumors [
2,
3]. Therefore, compared to other anatomical sites, retroperitoneal schwannomas (RS) are more likely to experience spontaneous bleeding and degeneration [
3]. The World Health Organization excluded the term “malignant schwannoma”; nevertheless, its malignant form might develop as malignant peripheral nerve sheath tumors (MPNST) [
4]. An early diagnosis is especially important for the malignant form of Schs since they are high-grade sarcomas that are extremely malignant, intensely invasive, prone to recurrence and metastasis, and have a low long-term survival rate [
5]. Schwannomas are found in the genetic autosomal dominant disorder called schwannomatosis [
6].
The typically, pathological appearance consists of spindle cells with elongated nuclei and an alternation of Antoni A (hypercellular) and Antoni B (hypocellular) patterns; some cases may also exhibit verocay bodies as an alternation of nuclear palisades with fibrillar regions. Malignant neoplasms such as synovial sarcoma or leiomyosarcoma are represented by Antoni A areas that do not exhibit nuclear palisading. The S-100 protein presents robust and diffuse positivity in the IHC analysis of these malignancies [
7]. Schs might be found in association with genetic autosomal dominant disorders such as neurofibromatosis type 2 [
8].
The authors present a rare case of surgically treated gigantic retroperitoneal Schwannoma causing symptoms consistent with its gigantic presentation.
2. Case Report
The patient was admitted to our department due to the obscure left-sided costal arch pain which lasted for three months prior to admission. Due to refractory pain, the patient underwent a computed tomography (CT) scanning of the abdomen, which revealed a large tumor mass which occupies the left hemiabdomen, compresses the diaphragm and visceral intrabdominal organs to the contralateral side. The smallest portion of the tumor is located at the level L3 and compresses the nerve root and neural foramen. Magnetic resonance (MR) imaging confirmed a large solid mass with the largest diameter of 25 cm and its origin at the left-sided L3 root. MRI was performed upon admission to our department (
Figure 1).
According to her medical history, the patient underwent cytologic tissue sampling, which confirmed Sch. The patient is a regular smoker with no significant comorbidities except arterial hypertension and obesity.
During the preoperative evaluation of the patient, no significant deviations were found, including laboratory findings. The preoperative physical examination of the patient included a muscle strength test of the left lower limb, which suggested a full range of antigravity movements with some resistance (grade 3+). Limited flexion and rotation in the lumbosacral region were noted, the left lower limb straight leg raising test (Lasegue) revealed motion of more than 35 degrees. The patient reported no significant pain and the test was mostly limited by obesity. Sphincter control was fully preserved.
Surgical technique: Surgery was performed multidisciplinary, in two stages. The original idea was to de-attach the Sch from its root at the level of L3 (
Figure 2). According to MRI, the authors believed that such a procedure could have preserved the L3 root and facilitate further transabdominal resection of the tumor with decreased risk of the nerve injury.
Therefore, the first stage in general anesthesia included neurosurgical approach to the lumbar spine. We performed the left-sided interlaminectomy at the level of L3 with a far-lateral approach. The tumor appeared as a whitish, solid mass. The nerve root was completely encased and there were no visible limits which would indicate tissue boundaries. Deattachment of the tumor from the osseal neural foramen was carried out carefully with respect to healthy anatomical boundaries using a high-speed drill, excochleation surgical instrument and rarely bipolar cauterization. After hemostasis, wound closure went uneventfully in a regular fashion.
Abdominal surgeons performed a median laparotomy as a second, consequent stage of surgery. After a meticulous approach, a large retroperitoneal tumor was presented in the entire left hemiabdomen. It had pushed the descending colon, left ureter and vascular structures towards the medial and right hemiabdomen. The tumor was completely removed and separated from the spinal column to which it was attached with solid adhesions (
Figure 3). Verriset hemostatic patch (Medtronic) was applied at the tumor origin site after its resection. The drain tube was also placed at the retroperitoneal space with no consequent bleeding during the postoperative recovery of the patient.
An early postoperative period was complicated by the partial lumbar wound dehiscence; the patient was obese and was lying on her back due to a large laparatomy wound. Ten days after surgery, we revised and re-sutured the wound, and antibiotic treatment was introduced. Meanwhile, pathohistological analysis revealed the diagnosis of schwannoma, low nuclear Ki-67 immunoreactivity, which delineated low tumor cell proliferation rate, cytologically bland spindle cells arranged in intersecting fascicles with nuclear palisading, and S100 immunohistochemical stain, which revealed strongly positive diffuse nuclear and cytoplasmic staining for S-100 protein (
Figure 4).
The follow-up MRI scan five months after surgery revealed an excellent postoperative outcome with no tumor relapse nor tumor remnants presented (
Figure 5). The patient also underwent somatosensory evoked potentials (SEP) examination for the tibial nerve, which detected normal recordings for the stimulated nerve. Nevertheless, electromyography (EMG) revealed total denervation of the left-sided L3 root. The patient is self-ambulatory with mild paresthesias down the left leg; physical therapy was proposed after the hospital discharge.
3. Discussion
The most common sites of Schwannomas (Schs) are extremities, head and neck, and their presentation in the abdomen is a rare finding, with only up to 3% occurring in the retroperitoneum [
9].
Schwannomas are benign tumors arising from the peripheral nerve sheaths and their malignant forms are rare findings. When malignant forms are presented, their clinical presentation is manifested as infiltrating and intraneural spreading as well as proliferating and herniating forms, mostly into the vessels. Malignant forms of Schs are rare and their symptoms depend on the anatomical site of its origin; also, malignant forms usually lead to the more complicated symptoms such as intestinal, pelvic and perineal disorders. Extraintestinal forms of Schs are more often benign and commonly lead to non-specific symptoms related to their size and consequent compression of surrounding structures. In such cases of extraintestinal Sch, its diagnosis is usually delayed due to paucity of symptoms, as presented in our case. Also, these tumors are well encapsulated with cystic degenerations and calcifications [
10].
Symptoms in our patient were obscure, as expected in such slowly proliferating tumors, and a preoperative biopsy confirmed a benign Sch, which was finally confirmed postoperatively by histopathological exam. Diagnostic tools are of great aid in planning the future steps of treating such tumors; ultrasonography is the first option, followed by CT scans, which were utilized in pre-planning in our case. MRI scan is a method of choice in distinguishing the soft tissues; nevertheless, despite its advances, one cannot determine the right nature of the neoplasm. What is more advanced in using an MRI scan is the possibility of preoperative planning in terms of other peritumoral surrounding soft tissues.
The diagnosis of Sch depends on immunohistochemistry and histopathologic exam with the recognition of the Antoni A and Antoni B areas which represent the histologic hallmark of Sch. In comparison, Antoni B regions are dominantly hypocellular and weakly organized, while Antoni A areas appear more organized. The majority of retroperitoneal lesions are encapsulated and S-100 protein positive [
11]. Schs are resistant to radiation and chemotherapy; therefore, surgical resection presents the first-line treatment. Due to their benign nature, there are very small chances of tumor recurrence following total surgical removal and the prognosis is excellent [
12].
The most appropriate approach in our case was lumbar detachment and consequent median laparatomy in order to achieve the best possible surgical result. Besides the removal of the tumor itself, it is necessary to achieve negative margins due to the possibility of tumor attachment to the surrounding anatomical structures and to avoid a possible tumor recurrence; therefore, further follow-up is necessary in order to recognize and avoid a possible onset of tumor recurrence or remnants.
Also, the quality of life in such patients depends on aforementioned criteria of how wide and safe surgical resection is. It is necessary to avoid intra-surgical damage of neural structures, such as the nerve roots, and to keep the patient neurologically intact. Nevertheless, sometimes the size of the tumor itself and neural encasement dictates the surgical approach, the limits of surgical resection and consequent postoperative deficits.
Author Contributions
Conceptualization, N.K. and B.K.; methodology, A.R. and A.S.K.; software, T.T.; validation, T.R., B.D. and S.Š.; formal analysis, A.R.; investigation, A.S.K.; resources, T.T.; data curation, T.R.; writing—original draft preparation, N.K.; writing—review and editing, B.D.; visualization, Z.P.; supervision, B.D.; project administration, H.V.; funding acquisition, N.K. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Data are contained within the article.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Helbing, D.L.; Schulz, A.; Morrison, H. Pathomechanisms in schwannoma development and progression. Oncogene 2020, 39, 5421–5429. [Google Scholar] [CrossRef] [PubMed]
- Davis, D.D.; Kane, S.M. Neurilemmoma; StatPearls: Treasure Island, FL, USA, 2021. [Google Scholar]
- Kalayci, M.; Akyüz, Ü.; Demirağ, A.; Gürses, B.; Özkan, F.; Gökçe, Ö. Retroperitoneal schwannoma: A rare case. Case Rep. Gastrointest. Med. 2011, 2011, 465062. [Google Scholar] [CrossRef] [PubMed]
- Louis, D.N.; Perry, A.; Wesseling, P.; Brat, D.J.; Cree, I.A.; Figarella-Branger, D.; Hawkins, C.; Ng, H.K.; Pfister, S.M.; Reifenberger, G.; et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro Oncol. 2021, 23, 1231–1251. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Zhou, S.; Wan, S.; Li, L.; Dong, W.; Ma, X.; Chu, H.; Zhong, Y. Rare retroperitoneal giant sacral schwannoma: A case report. Oncol. Lett. 2024, 27, 261. [Google Scholar] [CrossRef] [PubMed]
- Plotkin, S.R.; Messiaen, L.; Legius, E.; Pancza, P.; Avery, R.A.; Blakeley, J.O.; Babovic-Vuksanovic, D.; Ferner, R.; Fisher, M.J.; Friedman, J.M.; et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet. Med. 2022, 24, 1967–1977. [Google Scholar] [CrossRef] [PubMed]
- Drumond, G.; Nakagawa, S.; Costa, F.; de Souza, M.; Comunello, J.; Chung, W. Schwannoma Intraósseo: Relato De Caso E Revisão Da Literatura. Rev. Bras. Ortop. 2019, 55, 258–262. [Google Scholar] [CrossRef] [PubMed]
- Liu, Q.Y.; Lin, X.F.; Zhang, W.D.; Li, H.G.; Gao, M. Retroperitoneal schwannomas in the anterior pararenal space: Dynamic enhanced multi-slice CT and MR findings. Abdom. Imaging 2013, 38, 201–210. [Google Scholar] [CrossRef] [PubMed]
- Debaibi, M.; Essid, R.; Sghair, A.; Zouari, R.; Sahnoun, M.; Dhaoui, A.; Chouchen, A. Retroperitoneal schwannoma: Uncommon location of a benign tumor. Clin. Case Rep. 2022, 10, e05726. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hilton, D.A.; Hanemann, C.O. Schwannomas and their pathogenesis. Brain Pathol. 2014, 24, 205–220. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Choudry, H.A.; Nikfarjam, M.; Liang, J.J.; Kimchi, E.T.; Conter, R.; Gusani, N.J.; Staveley-O’Carroll, K.F. Diagnosis and management of retroperitoneal ancient schwannomas. World J. Surg. Oncol. 2009, 7, 12. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Shekouhi, R.; Chim, H. Patient demographics, tumor characteristics, and outcomes following surgical treatment of benign and malignant brachial plexus tumors: A systematic review. Int. J. Surg. 2023, 109, 972–981. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).